Investors

Webcast ImageWebcast
Edge Therapeutics, Inc. at the 16th Annual Needham Healthcare Conference (Replay)
April 5, 2017 at 2:20 p.m. ET
Edge Therapeutics, Inc. at the 16th Annual Needham Healthcare Conference
Wednesday, April 5, 2017 2:20 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Corporate Profile

Edge Therapeutics is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening conditions.

We believe EG-1962, our lead product candidate, can fundamentally improve patient outcomes and transform the management of aneurysmal subarachnoid hemorrhage, or aSAH, which is bleeding around the brain due to a ruptured brain aneurysm. Read More

Lastest News

April 21, 2017 - Edge Therapeutics Announces Conference Call on May 3, 2017 to Discuss First Quarter 2017 Financial Results
Read More
April 19, 2017 - Edge Therapeutics Announces $18 Million Registered Direct Offering of Common Stock
Read More
March 29, 2017 - Edge Therapeutics to Present at Needham & Company’s 16th Annual Healthcare Conference
Read More

Upcoming Events

DateTitle
May 3, 2017 8:30 a.m. ET
Q1 2017 Edge Therapeutics, Inc. Earnings Conference Call

Stock Information

EDGE (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$9.24
Change (%) Stock is Up 0.22 (2.44%)
Volume2,161
Data as of April 24, 2017 10:42 a.m. ET
Refresh quote

IR Contact

Gregory Gin
Email: ir@edgetherapeutics.com

Data provided by Nasdaq. Minimum 15 minutes delayed.

Printer Friendly Version Print PageE-mail this page Email PageRSS RSS FeedsE-mail Alerts Email AlertsView contacts IR ContactsDownload Financial Tear Sheet Financial Tear Sheet